These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 3929936)

  • 1. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.
    Coleman RE; Fogelman I; Rubens RD
    Eur J Surg Oncol; 1988 Oct; 14(5):423-8. PubMed ID: 2846366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling.
    Gallacher SJ; Fraser WD; Patel U; Logue FC; Soukop M; Boyle IT; Ralston SH
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():551-6. PubMed ID: 1964370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bone resorption and renal tubular reabsorption of calcium and phosphate in malignant and nonmalignant hypercalcemia.
    Buchs B; Rizzoli R; Bonjour JP
    Bone; 1991; 12(1):47-56. PubMed ID: 2054236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, causes and mechanism of hypercalcaemia in a hospital population in Hong Kong.
    Shek CC; Natkunam A; Tsang V; Cockram CS; Swaminathan R
    Q J Med; 1990 Dec; 77(284):1277-85. PubMed ID: 2290921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial benign hypercalcaemia. Study of a large family.
    Menko FH; Bijvoet OL; Fronen JL; Sandler LM; Adami S; O'Riordan JL; Schopman W; Heynen G
    Q J Med; 1983; 52(206):120-40. PubMed ID: 6310672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of the hypercalcaemia of malignancy with intravenous clodronate.
    Urwin GH; Yates AJ; Gray RE; Hamdy NA; McCloskey EV; Preston FE; Greaves M; Neil FE; Kanis JA
    Bone; 1987; 8 Suppl 1():S43-51. PubMed ID: 2961354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.
    Ralston SH; Fogelman I; Gardner MD; Dryburgh FJ; Cowan RA; Boyle IT
    Clin Sci (Lond); 1984 Feb; 66(2):187-91. PubMed ID: 6692653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parathyroid hormone related protein and hypercalcaemia in breast cancer.
    Bundred NJ; Ratcliffe WA; Walker RA; Coley S; Morrison JM; Ratcliffe JG
    BMJ; 1991 Dec; 303(6816):1506-9. PubMed ID: 1782489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypercalcaemia and metastatic bone disease: is there a causal link?
    Ralston S; Fogelman I; Gardner MD; Boyle IT
    Lancet; 1982 Oct; 2(8304):903-5. PubMed ID: 6126753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcaemia in cerebellar medulloblastoma: pathogenesis of solid tumour-associated hypercalcaemia.
    Arisaka O; Obinata K; Yabuta K; Ishimoto K; Sato K
    Eur J Pediatr; 1987 Jul; 146(4):434-6. PubMed ID: 3653140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcaemia in patients with advanced mammary cancer.
    Galasko CS; Burn JI
    Br Med J; 1971 Sep; 3(5774):573-7. PubMed ID: 5571456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
    Ralston SH; Alzaid AA; Gardner MD; Boyle IT
    Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilization hypercalcaemia with severe bone mineral loss and hypogonadism.
    Need AG; Morris HA; Horowitz M; Nordin BE
    Postgrad Med J; 1984 Jun; 60(704):415-9. PubMed ID: 6462982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone-related protein, bone metastases and hypercalcaemia of malignancy.
    Bundred NJ; Walls J; Ratcliffe WA
    Ann R Coll Surg Engl; 1996 Jul; 78(4):354-8. PubMed ID: 8712650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal tubular reabsorption of phosphate is positively related to the extent of bone metastatic load in patients with prostate cancer.
    Buchs N; Bonjour JP; Rizzoli R
    J Clin Endocrinol Metab; 1998 May; 83(5):1535-41. PubMed ID: 9589651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.
    Coleman RE; Rubens RD
    Br J Cancer; 1987 Oct; 56(4):465-9. PubMed ID: 3689664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.